Veraxa Biotech Appoints Raju Willener as New CFO
Veraxa Biotech (NASDAQ: VRXA) announced the appointment of Raju Willener as Chief Financial Officer, effective immediately. He replaces Carl von Halem and brings over three decades of experience in investment banking, corporate finance, capital markets, and asset management. Most recently, Willener served as CFO at Exentis Group AG, where he led M&A initiatives and financial strategy. The announcement comes amid a 10.87% increase in the company's share price following the news. Veraxa Biotech is currently navigating its post-merger valuation challenges while managing associated risks.
Topics: CFO appointment executive change